Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 11.75 Contact Hours.
Acknowledgment of Commercial Support:
This activity is supported by educational grants from AstraZeneca; Exact Sciences Corporation; Eisai Inc.; Genomic Health; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Seattle Genetics, Inc.
2nd Annual Precision Medicine Symposium: An Illustrated Tumor Board
September 25-26, 2020
Virtual, Interactive Conference!
Friday, September 25, 2020 - 1:00 PM - 5:00 PM EDT
Saturday, September 26, 2020 - 8:00 AM - 4:55 PM EDT
2nd Annual Precision Medicine Symposium Overview:
At this pan-tumor, interactive symposium, discussions will encompass the latest topics in major solid and liquid tumors. This meeting will cover key malignancies, including lung cancers, breast cancers, gastrointestinal cancers, genitourinary cancers, skin cancers, and hematologic malignancies, and feature keynote lectures focusing on precision medicine. High-impact sessions will focus on practical takeaways regarding the latest updates in next-generation sequencing, liquid biopsy, and cytogenetic testing. The expert faculty will review updates in targeted treatment, including tumor-agnostic indications based solely on genomic markers and other biomarkers. This program will emphasize the role of advanced genetic panel testing and the use of targeted therapies, as well as best practices for leveraging relevant actionable targets that drive clinical decision making, with a focus on data that is most relevant for patient care.
Benefits of Attending:
- Learn from the experts how to interpret tumor pathology reports to facilitate evidence-based treatment across malignancies
- Improve your knowledge about diagnostic and treatment-related data relevant to optimal multidisciplinary care
- Gain expert perspectives on the most relevant data regarding the current and evolving role of genomic assays in cancer management
- Learn about the latest clinical data regarding the use of biomarkers in qualifying patients for specific oncolytic therapies
Acknowledgment of Commercial Support:This activity is supported by educational grants from AstraZeneca; Exact Sciences Corporation; Eisai Inc.; Genomic Health; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Seattle Genetics, Inc.
This educational activity is directed toward pathologists and oncologists, as well as nurses and fellows, involved in the treatment and management of patients with cancer. Physician assistants, pharmacists, researchers, and other healthcare professionals may also participate.
Upon successful completion of this activity, you should be better prepared to:
- Evaluate clinical data regarding the use of biomarkers in qualifying patients for specific oncolytic therapies
- Interpret tumor pathology reports to facilitate evidence-based treatment across malignancies
- Summarize diagnostic and treatment-related data relevant to optimal multidisciplinary care
- Evaluate the most relevant data regarding the current and evolving role of genomic assays in cancer management
Physician in Chief Hackensack Meridian Health Oncology Care Transformation Service
Chairman & Chief Physician Officer - John Theurer Cancer Center
Lydia Pfund Chair for Lymphoma
Academic Chairman Oncology- Hackensack Meridian School of Medicine at Seton Hall University
Professor of Medicine – Georgetown University
2nd Annual Precision Medicine Symposium: An Illustrated Tumor Board Registration
3 Ways to Register:
- Online: Click here.
- Phone: Please call (888) 949-0045 or (609) 378-3701 (credit cards only).
- Fax: (609) 257-0705 (credit cards only).
Physicians' Education Resource®, LLC – PMC20
2 Clarke Drive, Suite 110
Cranbury, NJ 08512
|Nurses, PAs, Other Health Care Professionals||$49|
*FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes.
**INDUSTRY is defined by Physicians' Education Resource®, LLC (PER®) as any person employed by a for-profit organization, including biotech, financial, and pharmaceutical.
For registration assistance, please email email@example.com, or call (888) 949-0045 or (609) 378-3701.
A cancellation fee of 25% will be assessed on refunds requested prior to July 25, 2020, and a 50% fee on refunds requested on July 26, 2020, through August 25, 2020. No refunds will be made after August 25, 2020. There is no charge for substitution. Substitutions can only be applied to the same conference and only two substitutions will be honored.
In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.
Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.
Meeting information is accurate at the time of posting.
You must be logged in to PER to register for this meeting
Or Register for PER now